↓ Skip to main content

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort

Overview of attention for article published in Arthritis Research & Therapy, December 2011
Altmetric Badge

Citations

dimensions_citation
141 Dimensions

Readers on

mendeley
84 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort
Published in
Arthritis Research & Therapy, December 2011
DOI 10.1186/ar3544
Pubmed ID
Authors

Mandana Nikpour, Pravin Hissaria, Jillian Byron, Joanne Sahhar, Maree Micallef, William Paspaliaris, Janet Roddy, Peter Nash, Alan Sturgess, Susanna Proudman, Wendy Stevens

Abstract

The prevalence of antibodies to RNA polymerase III (anti-RNAP) differs among systemic sclerosis (SSc) cohorts worldwide. Previously reported associations of anti-RNAP include diffuse cutaneous disease, tendon friction rubs and renal crisis, with recent reports suggesting a close temporal association between malignancy and SSc disease onset among patients with anti-RNAP.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 1%
Unknown 83 99%

Demographic breakdown

Readers by professional status Count As %
Other 12 14%
Researcher 10 12%
Student > Doctoral Student 10 12%
Student > Master 9 11%
Student > Ph. D. Student 6 7%
Other 16 19%
Unknown 21 25%
Readers by discipline Count As %
Medicine and Dentistry 45 54%
Immunology and Microbiology 5 6%
Agricultural and Biological Sciences 4 5%
Nursing and Health Professions 2 2%
Mathematics 1 1%
Other 2 2%
Unknown 25 30%